[ACL] QoQ Quarter Result on 30-Sep-2021 [#Q1]

Stock
[ACL] Australian Clinical Labs Limited
Announcement Date
29-Sep-2021
Financial Year
2022
Quarter
30-Sep-2021 [#Q1]
Profit Trend
QoQ- 1,872.94%
YoY- 128.15%
Quarter Report
ACL's Result
ACL's Financial Summary
View:
Show?
Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 457,603 228,802 538,001 269,001 328,798 164,399 317,904 27.57%
PBT 69,956 34,978 184,944 92,472 5,379 2,690 81,274 -9.53%
Tax 21,842 10,921 54,656 27,328 2,063 1,032 24,201 -6.62%
NP 48,030 24,015 130,214 65,107 3,300 1,650 57,073 -10.89%
Tax Rate -31.22% -31.22% -29.55% -29.55% -38.35% -38.35% -29.78% -
Total Cost 409,573 204,787 407,787 203,894 325,498 162,749 260,831 35.20%
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin 10.50 10.50 24.20 24.20 1.00 1.00 17.95 -30.12%
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
EPS 0.24 0.12 0.65 0.32 0.02 0.01 0.28 -9.79%
EPS Diluted 0.24 0.12 0.65 0.32 0.02 0.01 0.28 -9.79%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.